ATRX
Adhera Therapeutics, Inc. [ATRX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ATRX Stock Summary
Top 10 Correlated Stocks
ATRX
In the News
ATRX Financial details
Company Rating
-
Market Cap
79.43K
Income
-2.53M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
20 May 2024
P/E
-0.03
Forward P/E
-
PEG
0
P/S
-
P/B
-
P/C
-
P/FCF
-0.17
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.52
EPS next Y
-
EPS next Q
-
EPS this Y
-108.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-1258.19%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-5738%
ROE
11%
ROC
0.05%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-25%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.01-0.6
52W High
-
52W Low
-
RSI
12
Rel Volume
0.79
Avg Volume
106.15K
Volume
84K
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
-98.75%
-
-
-
-
Beta
-0.098
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0001
Change
0%
Company Profile
- Volume Average 106.15K
- Market Capitalization 79.43K
- Employee 2
- CEO Mr. Andrew Albert Kucharchuk M.B.A.
- Headquarters Baton Rouge,LA,US
- IPO Date 1993-12-07
-
Website
https://adherathera.com 
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
